EU DTC rules to change?
The
UK's Medicines and Healthcare products Regulatory Agency (MHRA) is
seeking opinions on a European Commission (EC) proposal that would
allow drugmakers to disseminate certain information on prescription
medicines directly to European patients. More...
J&J fights for Remicade rights
Johnson & Johnson (J&J) is making a break for escape with
global sales of the rheumatoid arthritis treatment Remicade, which the
company currently shares with Schering-Plough via a distribution
agreement. More...
AstraZeneca & Merck in unique deal
In
a novel collaboration, pharma giants AstraZeneca and Merck will
investigate the potential benefits of combining their two early-stage
compounds for the treatment of solid cancer tumours. More...
Tweet tweet!
Follow Pharmaceutical Technology Europe on Twitter! More...
US issues new drug safety guidelines
A
discussion draft of the Food Safety Enhancement Act of 2009 has been
released, which also contains measures relating to drug safety. More...
Atherosclerosis vaccine receives EU funding
Austria-based
AFFiRiS AG is receiving financial support worth several hundred
thousand euro for its atherosclerosis vaccine development programme
from the European Union's EuroTransBio call. More...
Genetic link to drug-induced liver injury found
The
International Serious Adverse Event Consortium (SAEC), a nonprofit
partnership, has helped the FDA gain significant understanding of the
genetic basis for drug-induced liver injury (DILI). More...
RAPS enters Europe
The
Regulatory Affairs Professionals Society (RAPS) — the world's largest
international membership organization of regulatory professionals in
the medical device, pharmaceutical and biotechnology sectors — has
opened a European office in Brussels (Belgium) that will support
programmes, events and operations across Europe, as well as serve as
the region's headquarters. More...
Marketing authorization withdrawn for Biferonex
BioPartners
GmbH (Switzerland) has formally notified the European Medicines Agency
(EMEA) of its decision to withdraw the application of a centralized
marketing authorization for Biferonex (interferon beta 1a), 6
million-international-unit solution for injection, prefilled syringes
for subcutaneous administration. More...
|
| MeettheBoss |
The Pharmaceutical Industry have been targeted by the online Financial
Community MeettheBoss. MeettheBoss, originally focused on the financial
services sector, has launched a new section dedicated to the
Pharmaceutical Industry. The secure platform that MeettheBoss provided
for the finance executives allowed them to communicate openly, free
from vendors and the media. Over 40,000 members currently network on
the site, all of them protected by the secure walls that surround the
MeettheBoss site.
 Read more... |
|
|
|
|
|
|
| |
|
| |
| Packaging & labeling articles |
|
 |
|
